My guess is that ESRX and WAG will settle this dispute and both represent a good buying opportunity here. Here is a look at the charts on each:
Wednesday, September 28, 2011
JP Morgan lowers Walgreens price target...
JPMorgan lowers its price target on shares of Walgreen (WAG) to $35. Though the drugstore chain reported a Q4 earnings beat, the dispute with Express Scripts (ESRX) weighs heavy: "We remain cautious on WAG shares, given the significant potential earnings hit related to the ESRX dispute should there be no resolution."
My guess is that ESRX and WAG will settle this dispute and both represent a good buying opportunity here. Here is a look at the charts on each:
My guess is that ESRX and WAG will settle this dispute and both represent a good buying opportunity here. Here is a look at the charts on each:
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment